WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016097299) COMPOUND FOR TREATMENT OF MYOTONIC DYSTROPHY TYPE 1
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/097299    International Application No.:    PCT/EP2015/080508
Publication Date: 23.06.2016 International Filing Date: 18.12.2015
Chapter 2 Demand Filed:    18.10.2016    
IPC:
A61K 31/198 (2006.01), A61K 31/4439 (2006.01), A61K 31/4709 (2006.01), A61K 31/4745 (2006.01), A61P 21/00 (2006.01)
Applicants: UNIVERSITAT DE VALÈNCIA, ESTUDI GENERAL [ES/ES]; OTRI- Avda. Blasco Ibáñez 13 46010 Valencia (ES)
Inventors: ARTERO ALLEPUZ, Rubén Darío; (ES).
BARGIELA SCHÖNBRUNN, Ariadna; (ES).
LLAMUSÍ TROÍSI, Beatriz; (ES).
PÉREZ ALONSO, Manuel; (ES).
FERNÁNDEZ COSTA, Juan Manuel; (ES)
Agent: ILLESCAS TABOADA, Manuel; (ES)
Priority Data:
14198823.8 18.12.2014 EP
Title (EN) COMPOUND FOR TREATMENT OF MYOTONIC DYSTROPHY TYPE 1
(FR) COMPOSÉ POUR LE TRAITEMENT D'UNE DYSTROPHIE MYOTONIQUE DE TYPE 1
Abstract: front page image
(EN)Compound for treatment of myotonic dystrophy type The present invention relates to a compound, or a salt thereof, and a pharmaceutical composition comprising said compound, or a salt thereof, for use in the prevention and/or treatment of myotonic dystrophy type 1 in a patient, in particular by reducing the levels of autophagy and apoptosis that are elevated in myotonic muscular dystrophy type 1.
(FR)La présente invention concerne un composé, ou un sel de celui-ci, et une composition pharmaceutique comprenant ledit composé, ou un sel de celui-ci, destinés à être utilisés dans la prévention et/ou le traitement d'une dystrophie myotonique de type 1 chez un patient, en particulier par la réduction des taux d'autophagie et d'apoptose qui sont élevés dans des cas de dystrophie musculaire myotonique de type 1.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)